Moreover, patients that received one or more course of oral corticosteroids for asthma exacerbations in the year preceding study enrolment had significantly lower systemic IL-26 levels compared to the patients with asthma who had not received oral corticosteroids. This evidence concerns the gene IL26 and asthma.